Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform.
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint Read More »
